Cite
Risk of myocarditis after three doses of COVID‐19 mRNA vaccines in the United States, 2020–2022: A self‐controlled case series study.
MLA
Lai, Daoyuan, et al. “Risk of Myocarditis after Three Doses of COVID‐19 MRNA Vaccines in the United States, 2020–2022: A Self‐controlled Case Series Study.” Journal of Evidence-Based Medicine, vol. 17, no. 1, Mar. 2024, pp. 65–77. EBSCOhost, https://doi.org/10.1111/jebm.12595.
APA
Lai, D., Lim, D., Lu, J., Wang, H., Huang, T., & Zhang, Y. D. (2024). Risk of myocarditis after three doses of COVID‐19 mRNA vaccines in the United States, 2020–2022: A self‐controlled case series study. Journal of Evidence-Based Medicine, 17(1), 65–77. https://doi.org/10.1111/jebm.12595
Chicago
Lai, Daoyuan, Dickson Lim, Junfeng Lu, Han Wang, Tao Huang, and Yan Dora Zhang. 2024. “Risk of Myocarditis after Three Doses of COVID‐19 MRNA Vaccines in the United States, 2020–2022: A Self‐controlled Case Series Study.” Journal of Evidence-Based Medicine 17 (1): 65–77. doi:10.1111/jebm.12595.